7 Patents
- US124199532025Methods of Treatment or Prevention of Immune Responses and Inflammatory Diseases with Antagonistic CD40 Monoclonal Antibodies
Bristol-myers Squibb Company
0 cites - 0 cites
- US122028722025Interleukin-2/interleukin-2 Receptor Alpha Fusion Proteins and Methods of Use
Bristol-myers Squibb Company
0 cites - 0 cites
- 0 cites
- 0 cites
- US116135852023Nucleic Acids Encoding Antagonistic CD40 Monoclonal Antibodies
Bristol-myers Squibb Company
0 cites